Stonebridge Capital Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Stonebridge Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$98.98 - $115.74 $39,592 - $46,296	400 Added 800.0%	450 $52,000
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $24,956 - $45,520	-400 Reduced 88.89%	50 $5,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $11,784 - $16,934	-200 Reduced 30.77%	450 $28,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $47,531 - $60,395	550 Added 550.0%	650 $68,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $9,191 - $11,037	100 New	100 $11,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.